Search: onr:"swepub:oai:gup.ub.gu.se/182506" >
The safety of long-...
The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease
-
Decramer, Marc L (author)
-
Hanania, Nicola A (author)
-
- Lötvall, Jan, 1956 (author)
- Gothenburg University,Göteborgs universitet,Krefting Research Centre
-
show more...
-
Yawn, Barbara P (author)
-
show less...
-
(creator_code:org_t)
- 2013
- 2013
- English.
-
In: International journal of chronic obstructive pulmonary disease. - 1178-2005. ; 8, s. 53-64
- Related links:
-
https://gup.ub.gu.se...
-
show more...
-
https://doi.org/10.2...
-
show less...
Abstract
Subject headings
Close
- Inhaled long-acting bronchodilators are the mainstay of pharmacotherapy for chronic obstructive pulmonary disease (COPD). Both the twice-daily long-acting β(2)-adrenoceptor agonists (LABAs) salmeterol and formoterol and the once-daily LABA indacaterol are indicated for use in COPD. This review examines current evidence for the safety of LABAs in COPD, focusing on their effect on exacerbations and deaths.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Lungmedicin och allergi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Respiratory Medicine and Allergy (hsv//eng)
Keyword
- Adrenergic beta-2 Receptor Agonists
- adverse effects
- Albuterol
- adverse effects
- analogs & derivatives
- Blood Glucose
- analysis
- Cough
- chemically induced
- Ethanolamines
- adverse effects
- Headache
- chemically induced
- Humans
- Indans
- adverse effects
- Nasopharyngitis
- chemically induced
- Potassium
- blood
- Pulmonary Disease
- Chronic Obstructive
- drug therapy
- Quinolones
- adverse effects
- Respiratory Tract Infections
- chemically induced
- Spasm
- chemically induced
- Tachycardia
- chemically induced
- Tremor
- chemically induced
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database